ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

NHC vs SGRY // RSI-14 & 200D SMA MOMENTUM

National HealthCare Corporation (NYSE) VS. Surgery Partners Inc. (NASDAQ) • 15-METRIC TALLY: NHC 6 — SGRY 5
▲ RSI-14 & 200D SMA MOMENTUM LEADER: SGRY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NHC VS. SGRY) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC NHC SGRY SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 10.10% 9.90% +0.20 NHC /roic <GO>
EV/EBITDA & P/E Valuation 20.5x 9.7x +10.80 SGRY /valuation <GO>
Free Cash Flow Yield 4.47% 6.44% -1.97 SGRY /fcf-yield <GO>
Operating Margin 8.50% 45.80% -37.30 SGRY /operating-margins <GO>
Net Profit Margin 7.90% -9.20% +17.10 NHC /net-margins <GO>
Revenue Growth (YoY) 16.10% 6.60% +9.50 NHC /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 1.16% 0.00% +1.16 NHC /dividend-safety <GO>
Altman Z-Score & Debt/Equity 6.61 0.67 +5.94 NHC /balance-sheet <GO>
Piotroski F-Score Quality 8/9 8/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum ACTIVE 37.2 86.2 -49.00 SGRY /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 0.99 — TIE /macro-sensitivity <GO>
Forward P/E Multiple 23.3x 22.0x +1.30 SGRY /forward-pe <GO>
Enterprise Scale & Market Cap $3.23B $3.04B $189.8M NHC /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR NHC REV SGRY REV NHC GROSS % SGRY GROSS % NHC FCF SGRY FCF
FY 2025 $1.52B $1.09B — — $148.6M $195.6M
FY 2024 $1.31B $976.6M — — $79.7M $209.7M
FY 2023 $1.14B $918.4M — — $111.2M $293.8M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NHC // BETA —
SGRY // BETA 0.99